Zhu Xiang-Gao, Li Jin-Luan, Li Xiao-Fan, Li Yong-Heng, Ni Qian-Yu, Wang Lin, Zhang Shan-Wen, Gu Jin, Cai Yong, Lin Chi
Departments of *Radiation Oncology ‡Colorectal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Peking University Cancer Hospital, Beijing Cancer Hospital and Institute, Beijing †Department of Radiation Oncology, Teaching Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, Fuzhou, China §Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE.
Am J Clin Oncol. 2017 Jun;40(3):266-273. doi: 10.1097/COC.0000000000000142.
To evaluate local control and survival in locally advanced rectal adenocarcinoma patients who underwent a preoperative 2-week course of radiotherapy (RT) and to identify prognostic factors influencing the survival rate.
We analyzed 377 consecutively treated patients with locally advanced (T3/T4 or node positive) rectal adenocarcinoma. All patients underwent a preoperative 2-week course of RT (30 Gy in 10 fractions) followed by curative surgery. Regression model was used to examine prognostic factors for the disease-free survival (DFS) and overall survival (OS) rates. The Statistical Analysis System software package, version 9.3, was used for analysis.
The median follow-up for all living patients was 63.8 months (range, 5.1 to 131.7). The 5-year DFS and OS rates were 64.5% (95% CI, 59.0-69.4) and 75.6% (95% CI, 70.5-80.0), respectively. The 5-year cumulative incidences of local recurrence and distant metastases were 5.4% (95% CI, 2.9-7.9) and 29.0% (95% CI, 23.9-30.1), respectively. The pathologic complete response rate was achieved in 17 patients (4.5%). The Multivariate Cox Regression model showed that factors affecting DFS were the surgical technique, pre-RT pathologic grade, ypT, ypN, and comorbidity; and factors improving OS were low anterior resection, low pre-RT grade, low ypT, and low ypN.
Patients treated with preoperative RT with 30 Gy in 10 fractions had similar local control, 5-year DFS and OS to reported long course RT regimen. The surgical technique, pre-RT pathologic grade, ypT, and ypN seemed to affect the OS. Further study on combining a 2-week course of preoperative RT with concurrent chemotherapy would be warranted.
评估接受术前2周放疗(RT)的局部晚期直肠腺癌患者的局部控制情况和生存率,并确定影响生存率的预后因素。
我们分析了377例连续接受治疗的局部晚期(T3/T4或淋巴结阳性)直肠腺癌患者。所有患者均接受术前2周的放疗疗程(10次分割,共30 Gy),随后进行根治性手术。采用回归模型检查无病生存期(DFS)和总生存期(OS)率的预后因素。使用版本9.3的统计分析系统软件包进行分析。
所有存活患者的中位随访时间为63.8个月(范围为5.1至131.7个月)。5年DFS率和OS率分别为64.5%(95%CI,59.0 - 69.4)和75.6%(95%CI,70.5 - 80.0)。局部复发和远处转移的5年累积发生率分别为5.4%(95%CI,2.9 - 7.9)和29.0%(95%CI,23.9 - 30.1)。17例患者(4.5%)达到病理完全缓解率。多变量Cox回归模型显示,影响DFS的因素有手术技术、放疗前病理分级、ypT、ypN和合并症;改善OS的因素有低位前切除术、放疗前低分级、低ypT和低ypN。
接受10次分割共30 Gy术前放疗的患者,其局部控制情况、5年DFS和OS与报道的长疗程放疗方案相似。手术技术、放疗前病理分级、ypT和ypN似乎影响OS。有必要进一步研究术前2周放疗疗程与同步化疗联合应用的情况。